Company / Total Debt
Arcturus Therapeutics Holdings Inc. Total Debt History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$15.3M
FY2021
5-year range
$15.3M / $15.3M
FY2019-FY2021
Trend
+10.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt remained relatively stable over the past 3 years, with values between $14M and $15M.
Based on SEC 10-K filings.
$15M in FY2021.
Increased from $15M to $15M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, total debt increased 10.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $15.3M | +10.5% |
| FY2020 | $13.8M | -7.7% |
| FY2019 | $15.0M | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 24, 2026